SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 11.70% in the revenue at Rs. 9523.10 millions was reported in the June 2024 quarter as compared to Rs. 8525.80 millions during year-ago period.The Company has registered profit of Rs. 1732.30  millions for the quarter ended June 2024, a growth of 19.82%  over Rs. 1445.70 millions millions achieved in the corresponding quarter of last year.OP of the company witnessed a marginal growth to 2785.40 millions from 2399.60 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 9523.10 8525.80 11.70 9523.10 8525.80 11.70 32986.40 28841.60 14.37
Other Income 51.60 51.30 0.58 51.60 51.30 0.58 346.80 86.50 300.92
PBIDT 2785.40 2399.60 16.08 2785.40 2399.60 16.08 9141.00 6733.40 35.76
Interest 43.20 112.10 -61.46 43.20 112.10 -61.46 405.20 343.10 18.10
PBDT 2742.20 2287.50 19.88 2742.20 2287.50 19.88 8735.80 6390.30 36.70
Depreciation 400.10 306.50 30.54 400.10 306.50 30.54 1352.40 1119.90 20.76
PBT 2342.10 1981.00 18.23 2342.10 1981.00 18.23 7383.40 5270.40 40.09
TAX 609.80 535.30 13.92 609.80 535.30 13.92 1949.80 1381.50 41.14
Deferred Tax 83.70 133.00 -37.07 83.70 133.00 -37.07 494.90 548.00 -9.69
PAT 1732.30 1445.70 19.82 1732.30 1445.70 19.82 5433.60 3888.90 39.72
Equity 155.20 154.80 0.26 155.20 154.80 0.26 155.20 154.80 0.26
PBIDTM(%) 29.25 28.15 3.92 29.25 28.15 3.92 27.71 23.35 18.70

JB Chem & Pharma Share Price

2011.90 13.25 (0.66%)
15-Apr-2026 11:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.60
Dr. Reddys Lab 1214.00
Cipla 1224.85
Zydus Lifesciences 931.60
Lupin 2343.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×